Cyclosporine in ocular surface inflammation – (Eye 31, 665 (May 2017))
Cyclosporine in ocular surface inflammation Eye 31, 665 (May 2017). doi:10.1038/eye.2017.5 Author: P Hossain
99Tcm-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy – (Eye 31, 668 (May 2017))
99Tcm-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy Eye 31, 668 (May 2017). doi:10.1038/eye.2017.42 Authors: B Sun, Z Zhang, C Dong, Y Zhang, C Yan & S Li
Short-term effects of intravitreal ranibizumab and bevacizumab administration on 24-h ambulatory blood pressure monitoring recordings in normotensive patients with age-related macular degeneration – (Eye 31, 677 (May 2017))
Short-term effects of intravitreal ranibizumab and bevacizumab administration on 24-h ambulatory blood pressure monitoring recordings in normotensive patients with age-related macular degeneration Eye 31, 677 (May 2017). doi:10.1038/eye.2016.305 Authors: A Sengul, R Rasier, C Ciftci, O Artunay, A Kockar, H Bahcecioglu & E Yuzbasioglu
Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy – (Eye 31, 684 (May 2017))
Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy Eye 31, 684 (May 2017). doi:10.1038/eye.2016.303 Authors: A Meireles, C Goldsmith, I El-Ghrably, A Erginay, M Habib, B Pessoa, J Coelho, T Patel, R Tadayoni, P Massin, J Atorf & A J Augustin
Surgical outcomes of external dacryocystorhinostomy and risk factors for functional failure: a 10-year experience – (Eye 31, 691 (May 2017))
Surgical outcomes of external dacryocystorhinostomy and risk factors for functional failure: a 10-year experience Eye 31, 691 (May 2017). doi:10.1038/eye.2016.308 Authors: M J Lee, S I Khwarg, I H Kim, J H Choi, Y J Choi, N Kim & H-K Choung